A task-oriented circuit training in multiple sclerosis: a feasibility study by unknown
Straudi et al. BMC Neurology 2014, 14:124
http://www.biomedcentral.com/1471-2377/14/124RESEARCH ARTICLE Open AccessA task-oriented circuit training in multiple sclerosis:
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Background: The aim of this study was to evaluate the safety, feasibility and preliminary effects of a high-intensity
rehabilitative task-oriented circuit training (TOCT) in a sample of multiple sclerosis (MS) subjects on walking competency,
mobility, fatigue and health-related quality of life (HRQoL).
Methods: 24 MS subjects (EDSS 4.89 ± 0.54, 17 female and 7 male, 52.58 ± 11.21 years, MS duration 15.21 ± 8.68 years)
have been enrolled and randomly assigned to 2 treatment groups: (i) experimental group received 10 TOCT sessions over
2 weeks (2 hours/each session) followed by a 3 months home exercise program, whereas control group did not receive
any specific rehabilitation intervention. A feasibility patient-reported questionnaire was administered after TOCT. Functional
outcome measures were: walking endurance (Six Minute Walk Test), gait speed (10 Meter Walk Test), mobility (Timed Up
and Go test) and balance (Dynamic Gait Index). Furthermore, self-reported questionnaire of motor fatigue (Fatigue
Severity Scale), walking ability (Multiple Sclerosis Walking Scale – 12) and health-related quality of life (Multiple
Sclerosis Impact Scale – 29) were included. Subjects’ assessments were delivered at baseline (T0), after TOCT (T1)
and 3 months of home-based exercise program (T2).
Results: After TOCT subjects reported a positive global rating on the received treatment. At 3 months, we found a
58.33% of adherence to the home-exercise program. After TOCT, walking ability and health-related quality of life
were improved (p < 0.05) with minor retention after 3 months. The control group showed no significant changes
in any variables.
Conclusions: This two weeks high-intensity task-oriented circuit class training followed by a three months home-based
exercise program seems feasible and safe in MS people with moderate mobility impairments; moreover it might improve
walking abilities.
Trial registration: NCT01464749
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Multiple sclerosis (MS) is a chronic and progressive
neurologic disease that commonly affects young adults
worldwide and it represents a major cause of disability
over time [1,2]. In this population gait and mobility
impairments could have a negative impact on personal
activities not only restricted to motor domains and* Correspondence: s.straudi@ospfe.it
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unless otherwise stated.participation but also to quality of life [3,4]. There are
several studies showing a benefit of physical therapy on
walking function, mobility [5-9] and fatigue [10-12]; for
this reason recent reviews and international guidelines
recommend exercise for MS population [13,14]. None-
theless, the task-oriented circuit training (TOCT) ap-
proach hasn’t been studied enough in people with MS
(PwMS) and gait and mobility disorders. TOCT is based
on workstations that reproduce physical activities that
the subject usually performs during daily living (i.e. walking,
climbing stairs, maintain balance) with the aim of pro-
moting motor learning and task retention. In addition,
a major characteristic of this rehabilitative interventionLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tional physiotherapy session, is nearer to the number
of repetitions needed to achieve and maintain motor
learning of these movements [15]. Moreover, TOCT
has been designed for small groups of subjects requir-
ing only one physiotherapist compared with conven-
tional rehabilitation session in which the ratio is 1:1,
giving also the advantage of reducing costs of rehabili-
tation. Previous studies [16,17] have shown that TOCT
is a good method to improve locomotor function and
mobility in stroke survivors.
The rationale of our study is based on growing evi-
dences [18] that demonstrate how human adult brain is
capable of significant adaptations providing that the
quantity (duration and frequency) and quality (task-
specificity) of interventions are appropriate to facilitate
enhanced neural reorganization and upper limb motor
recovery in chronic stroke survivors [19]. Also, recent
neuroimaging studies highlighted how adaptive brain
plasticity [20,21] and motor learning [22] are preserved
even in progressive MS subjects and rehabilitative strat-
egies that harness cortical reorganization of motor func-
tion might be an option even in this chronically disabled
subjects. Task oriented circuit training (TOCT) is an
intensive task-specific intervention, for this reason we
designed a pilot randomized-controlled trial: (i) to test
the safety, feasibility and acceptability of a two weeks
high-intensity task oriented circuit training in multiple
sclerosis subjects with moderate gait impairments; (ii) to
assess its preliminary effects on walking, mobility, fa-
tigue and quality of life; (iii) to evaluate the adherence to
a three months home based training program that
followed TOCT; (iv) to determine TOCT effect sizes
and the sample needed for a future RCT study.
Methods
This is a single-blind randomized controlled pilot trial.
Subjects were recruited at the outpatient clinic of the
Physical Medicine and Rehabilitation Department (Fer-
rara University Hospital). Informed written consent was
obtained from eligible subjects. The research study has
been reviewed and approved by the Ferrara University
Hospital Ethics Committee and registered in ClinicalTrial.
gov database (NCT01464749). The inclusion criteria were:
males and females, age 18 to 75, diagnosis of MS (primary
or secondary progressive, relapsing-remitting), without re-
lapses in the preceding 3 months, mild to moderate gait
impairments referred to Expanded Disability Status Scale
(EDSS) score between 4 and 5.5. Subjects were able to walk
for at least 100 meters with no constant assistance
(cane, crutch or brace) required. The exclusion criteria
were: other conditions that may affect motor function,
impaired cognitive functioning (Mini Mental Status Exam-
ination score less than 24). Subjects were randomized toTOCT (experimental group) or usual care (control group)
through a block randomization approach. Eligible subjects
were randomly assigned into a 1:1 ratio to receive experi-
mental treatment (task-oriented circuit training), or no spe-
cific treatment (usual care). The randomization scheme
was generated by using the web site Randomization.com
(http://www.randomization.com). The experimental group
received 10 task-oriented training sessions (Monday-Friday)
over 2 weeks; each session lasted 2 hours. Control group
did not receive any intervention.
Task-oriented circuit training
TOCT included six different workstations in which sub-
jects exercised for 5 minutes in each one (3 minutes of
exercises and 2 minutes of rest). During each session,
subjects underwent 2 laps that took about 60 minutes
(6 workstation × 5 minutes × 2 laps), with 10 minutes of
rest after each lap. In addition, walking endurance was
trained by 30 minutes walking on the treadmill including
rests if necessary. For further details on training protocol
see Table 1. This was a progressive circuit and subjects
while exercising received feedbacks (visual and auditory)
by the physiotherapist. Rests were used to discuss about
difficulties and to provide further feedbacks. One ses-
sion included up to 3 patients and lasted 120 minutes,
5 days/week for 2 weeks.
Home-based training program
After the supervised 2 weeks, a home- exercise illus-
trated brochure was given to subjects so that they could
independently train for the following 3 months. It in-
cluded similar exercises that subjects learned during the
2 weeks, gait training (overground or treadmill), stretch-
ing and strengthening exercises. We suggested an inde-
pendent home training 3 times/week (60 minutes/each
session). Our principal aim was to retain positive effects
on walking competency and function. Subjects were
asked to record in a diary the intensity and duration of
exercise; they were allowed to call hospital to have fur-
ther information and feedbacks.
Usual care (UC)
The control group (UC) did not receive any specific re-
habilitation treatment for gait performance and mobility
improvement.
During the entire study, both groups were authorized,
at will, to exercise in non-rehabilitative contexts.
Outcome measures
Outcome measures were both functional tests (gait speed,
walking endurance, mobility, balance) and self-reported
questionnaires (fatigue, health-related quality of life and
walking ability). All measures were assessed the week prior




N. of therapists 1 experienced physiotherapist
Intensity (I) I: 2 weeks, 5 days per week, 120 minutes
Progression (P) P: increasing the number of repetitions completed in 3 minutes at a workstation and increasing treadmill speed
Exercises Workstations:
1: Step (the patient goes up and down a 20 cm step both with left and right foot)
2: Slalom (the patient kicks a ball walking through a slalom exercise, formed by 4 cones that are 1 m distant from each other)
3: Tandem exercise (the patient walks in tandem using a line as a guide. If he/she is not able to put one foot in front of the other,
it is allowed to do a wider and longer step as long as it is challenging)
4: Goals (the patient must touch with the tip of the foot a goal that is positioned on a mirror in front of him. If necessary,
he can use a lateral support)
5: Obstacles (the patient must pass 5 obstacles, 3 of which are 5 cm high)
6: Long step (the patient must walk performing long steps (at least 40-50 cm long) using some signs on the floor as a guide)
Subjects exercise for 3 minutes at each workstation followed by a 2 minutes break
7: Treadmill (the patient should walk up to 30 minutes at speed between 0.9 and 2.9 km/h. The speed is self selected by the
subject, who can also take a break if she/he needs to)
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and the 3 months home-based training program (T2).
10 Meter Walk Test (10MWT)
It assesses walking speed over 10 meters. It has been
tested on different kind of subjects (both with neurolo-
gical and orthopaedics conditions), including MS [23,24].
The subject walks in total for 14 meters: 2 m for acceler-
ation and 2 m for deceleration, gait speed is calculated for
the 10 m distance between them. The test is performed
three times and best trial is used for analysis.
Six Minute Walk Test (SMWT)
Walking endurance was measured with SMWT, a feas-
ible, reproducible and reliable measure in MS subjects
[25]. Subjects were instructed to walk up and down a
20m walkway as far as possible in 6 minute.
Timed Up and Go test (TUG)
Subjects were given verbal instruction to stand up from
a chair, walk 3 meters, cross a line marked on the floor,
turn around, walk back, and sit down. Subjects per-
formed 3 trials and their best performance was used for
analysis [26].
Dynamic Gait Index (DGI)
It was developed as a clinical tool to assess gait, balance
and risk of fall. It doesn’t evaluate only usual steady-
state walking, but also walking during more challenging
task (i.e. cross obstacles, slalom). Eight functional walk-
ing tests are performed by the subject and scored out of
three (maximum total score is 24). Scores of 19 or less
have been related to an increased risk of falls [27,28].Fatigue Severity Scale (FSS)
Fatigue was monitored through a questionnaire, Fa-
tigue Severity Scale (FSS) which evaluates fatigue in
MS and other conditions [29]. Essentially, the FSS
consists of answering a short questionnaire that re-
quires the subjects to rate their level of fatigue. Sub-
jects were asked to read each statement and circle a
number from 1 to 7, depending on how appropriate
they felt the statement applied to them over the pre-
ceding week.Multiple Sclerosis Walking Scale – 12 (MSWS-12)
This questionnaire assesses the impact of MS on walking
ability. It is formed by 12 items, asking the patient about
his perception on gait speed, running, confidence as-
cending/discending stairs, balance and fatigue. As in the
MSIS 29, the total score is obtained by the sum of the
score of each item (0-5) and then transformed into a
value from 0 to 100. Again, a higher score represents a
major walking disability [30].Multiple Sclerosis Impact Scale – 29 (MSIS-29)
This is an health-rated quality of life questionnaire that
assesses the impact of MS on physical and psycho-
logical functions. It is formed by 29 items on ADL I
and II: 20 about physical activity and 9 of psychological
status of the person. Each item can be scored with a
value from 0 to 5; total score is given by the sum of all
the items and then is transformed in a range from 0 to
100. A higher value correspond to a worse perception
of subject’s HRQoL [31].
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At the end of the 2 weeks, subjects who underwent TOCT
received a questionnaire formed by twelve questions on
their opinions and acceptability referred to the treatment
received (for further details see Additional file 1).
Biostatistical analysis
Descriptive statistic (mean, median, standard deviation,
percentiles and confidence interval) was used to describe
sample at T0, T1, T2. Baseline characteristics (sex, age,
MS type, MS duration, EDSS score) and clinical tests
(SMWT, 10 mWT, TUG, DGI, FSS, MSIS-29 and MSWS-
12) were compared among groups to assess the quality of
randomization. Graphics frequency and Shapiro-Wilk Test
were performed to assess variance in order to fulfill the
essential assumptions for parametric statistical analysis for
continuous variables. To try reducing Type I error, since
variables were normally distributed, we choose ANOVA
repeated measures for continuous variables (SMWT,
10 mWTand TUG) and Friedman test [32] for ordinal vari-
ables (DGI, MSIS-29 and MSWS-12, FSS) to test within-
group differences. Post-hoc analysis have been performed
when p < 0.05. Differences in mean changes from baseline
(T0) after TOCT (T1) and 3 months home-based exercise
(T2) were tested with un-paired t-test or Mann Whitney
Test among groups. In order to calculate a sample size for
a larger RCT, we used d (Cohen) [33]. An intention-to-treat
analysis was carried out, i.e. in case of missing data (lost to
follow-up) the last available value was considered (last











Age (years) 52.58 (11.21) 49.92
53.50 51.5
MS duration (years) 15.21 (8.68) 12.16
15 10
EDSS score 4.89 (0.54) 4.95 (0
5 5
TOCT = task-oriented circuit training. UC = usual care. MS =multiple sclerosis. RR = re
EDSS = Expanded Disability Status Scale.
*Pearson Chi-square.
**Mann-Whitney test.was performed with STATA software, statistical soft-
ware v12.1 college station, Texas. Significance level
was set at 0.05.
Results
Twenty-four PwMS have been assessed for eligibility in an
outpatient rehabilitation clinic (Ferrara University Hospital).
After the preliminary visit, all subjects (17 female, 7 male,
age 52.58 ± 11.21, 15.21 ± 8.68 years from MS onset) were
included in the study. They were randomized into groups:
twelve were allocated to TOCT and twelve to UC.
Demographic and clinical characteristics are summa-
rized in Table 2. 37.5% of subjects received disease-
modifying therapy (DMT) during the entire study
(8.33% immunosuppressive treatments, 16.66% inter-
feron beta, 4.16% glatiramer acetate and 8.33% fingolimod);
20.83% of them received therapies for MS symptoms man-
agement (i.e. spasticity, depression, pain). We didn’t report
significant differences in DMT or symptomatic therapies
among groups at baseline or any changes in pharmaco-
logical treatments during the study.
All subjects completed the 2 weeks training, while we
lost 3 subjects at 3 months follow-up in UC group. The
clinical study flow-chart has been reported in Figure 1.
Functional tests (walking endurance, speed, balance,
mobility)
A repeated-measures analysis of variance for SMWT,
10MWT and TUG and Friedman test for DGI revealed









(7.51) 55.25 (13.82) 0.16
58
(6.91) 18.25 (9.46) 0.09
18
.61) 4.83 (0.49) 0.56
4.75




Allocated to Usual Care group (n=12)
Received allocated intervention (n=12)
Allocated to TOCT group (n=12) 
Received allocated intervention (n=12)
Lost to follow-up (n=0) Lost to follow-up (denial) (n=3)
Analyzed (n=12) Analyzed (n=12)
Randomized (n=24)
Allocation 1:1
Figure 1 Study flow diagram.
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were found in SMWT after TOCT (p < 0.05). Descrip-
tive statistics are shown in Table 3.Patient-reported questionnaires (fatigue, walking ability,
health-related quality of life)
MSIS-12 scores were improved in TOCT group (F(2,22) =
3.81, p < 0.05). MSIS-29 physical (F(2,22) = 3.66, p < 0.05)
and psychological (F(2,22) = 3.55, p < 0.05) score improved in
TOCT group and decreased in UC group (F(2,22) = 3.66,
p < 0.05; F(2,22) = 4.28, p < 0.05) over time. Multiple compar-
isons were significant T0-T1 and T0-T2 in both groups.
Between-group differences were found in MSWS-12 and
MSIS-29 physical and psychological scores after TOCT
(p < 0.01) and in MSIS-29 psychological score even after
3 months of home-based exercise (p < 0.05). Descriptive
statistics are shown in Table 4.Feasibility patient-reported questionnaire
All subjects (n = 12) completed the questionnaire. On a
Visual Analog Scale (VAS) 0-10 they reported a positive
global rating on treatment received (9.1), considered the
time duration adequate (8.5), the goals were achievable
(7.6), the feedbacks provided during sessions were easy
to understand (9.9), they enjoyed the training (8.4) and
were satisfied by their own results (8.7). At the end of
each session they felt physically tired (7), however they
didn’t report the need of extra rests (0.25). The majority
identified the treadmill (50%) as the exercise where they
had best results whereas goals workstation (41.6%)
where they had their worst; they considered slalom andtandem exercise workstation (25%) as much more en-
joyable, while goals workstation as much more boring
(33.33%).Home based exercise adherence
At 3 months, 7/12 subjects (58.33%) completed their
diary with home-exercise program and returned them to
investigators. Considering the SMWT, we didn’t find fur-
ther gains in subjects who completed the 3 months exer-
cise program (good adherence sub-group) compared
with subjects who didn’t report any information on their
home exercise training (poor adherence sub-group).
Specifically, at three months the good adherence sub-
group (n = 7) decreased by -13.28 ± 6.72 m compared to
post-TOCT, while the poor adherence sub-group (n = 5)
of - 4.64 ± 32.37 m (n.s.).Sample size calculation
Our preliminary results allowed us to define a sample
size for a following RCT study. Considering walking en-
durance as primary outcome (SMWT), we found a
TOCT effect size (d) of 0.85 in multiple sclerosis sub-
jects (EDSS < 6). This value is based on a walking endur-
ance improvement in TOCT group of 20.05 ± 25.06 m,
compared to -9.95 ± 42.84 m in control group. Given
equal allocation (1:1) between treatment and control
arms, ad using 80% power and alpha of 5%, we would
need 46 subjects (23 TOCT + 23 usual care) to complete
the study. Conservatively, we expect a 10% rate of drop-
out, thus the sample size will be increased by 10% to
51 subjects.
Table 3 Clinical results
TOCT (n=12) UC (n=12)
Mean (SD) Median
(25th-75th Percentile)




Pre- TOCT 290.67 (72.92) 283.40 (215.70 – 355.6) 244.33 – 337 285.72 (79.15) 298.40 (230.00 – 329.80) 235.42 – 336.01
Post- TOCT 310.72 (73.73) 316.20 (237.50 – 371.60) 263.87 – 357.57 275.77 (70.65) 293.40 (227.80 – 333) 230.88 – 320.66
3 months follow-up 301.03 (72.58) 308.50 (230.80 – 359.80) 254.92 – 347.15 258.73 (100.80) 274.30 (167.8 – 312.8) 194.69 – 322.78
TUG (s)
Pre- TOCT 10.64 (2.48) 9.89 (9.06 – 11.85) 9.06 – 12.21 12.10 (4.00) 11.19 (9.24 – 15) 9.56 – 14.63
Post- TOCT 10.05 (1.89) 9.55 (8.56 – 10.93) 8.85 – 11.25 12.23 (3.78) 11.61 (9.27 – 14.07) 9.82 – 14.63
3 months follow-up 10.50 (2.03) 9.56 (9.08 – 11.98) 9.20 – 11.78 12.43 (3.92) 12.25 (9.89 – 14.22) 9.94 – 14.93
10MWT (m/s)
Pre- TOCT 1.08 (0.23) 1.11 (0.94 – 1.20) 0.94 – 1.23 1.03 (0.30) 0.99 (0.77– 1.19) 0.84 – 1.22
Post- TOCT 1.13 (0.24) 1.10 (1.00 – 1.29) 0.98 – 1.28 1.02 (0.23) 1.03 (0.81 – 1.15) 0.87 – 1.16
3 months follow-up 1.15 (0.19) 1.19 (1.01 – 1.30) 1.02 – 1.27 0.99 (0.30) 0.87 (0.82 – 1.14) 0.80 – 1.19
DGI
Pre- TOCT 16.83 (3.56) 17 (15.5 – 19.5) 14.57 – 19.10 14.75 (4.92) 14 (12.5 – 18) 11.62 – 17.88
Post - TOCT 17.67 (3.11) 18 (16 – 20) 15.69 – 19.65 14.75 (4.14) 16 (12 – 18) 12.12 – 17.38
3 months follow-up 17.75 (3.93) 18 (14.5 – 10.5) 15.25 – 20.25 13.75 (3.86) 14 (11.5 – 17) 11.29 – 16.21
TOCT = task-oriented circuit training; UC = usual care; SMWT= Six Minute Walk Test; TUG= Timed Up and Go test; 10MWT = 10 Meter Walk Test; DGI = Dynamic Gait Index.
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This is a proof-of-concept study with the aim of opti-
mizing components of a novel rehabilitative intervention
for PwMS with moderate mobility impairments. We
proposed a high-intensity task-specific training whichTable 4 Questionnaire results
TOCT (n = 12)
Mean (SD) Median (25th-75th percentile) 95%
MSIS-29 Psy (0-100)
Pre- TOCT 51.66 (20.61) 53.33 (32.22 – 64.44) 38.5
Post- TOCT 41.85 (15.73) 42.22 (30.00 – 46.66) 31.8
3 months follow-up 42.96 (16.20) 43.33 (29.44 – 56.11) 32.6
MSIS-29 Phys (0-100)
Pre- TOCT 50.83 (15.60) 53.00 (45.50 – 63.50) 40.9
Post- TOCT 44.41 (11.32) 43.00 (39.25 – 50.50) 37.2
3 months follow-up 49.16 (11.00) 48.00 (41.25 – 58.25) 42.1
MSWS-12 (0-100)
Pre- TOCT 63.06 (14.00) 66.67 (57.50 – 71.67) 54.1
Post- TOCT 52.36 (14.06) 53.33 (42.5 – 62.5) 43.4
3 months follow-up 65.42 (16.04) 63.33 (55 – 76.67) 55.2
FSS
Pre- TOCT 5.43 (1.23) 5.22 (4.94 – 6.50) 4.65
Post- TOCT 5.05 (1.52) 5.44 (4.59 – 6.11) 4.09
3 months follow-up 5.63 (0.78) 5.78 (5.09 – 6.17) 5.13
TOCT = task-oriented circuit training; UC = usual care; MSIS-29 Psy and Phys = Multip
MSWS-12 =Multiple Sclerosis Walking Scale – 12; FSS = Fatigue Severity Scale.includes several principles of experience-dependent neu-
roplasticity such as specificity, repetition and intensity
[18]; for this reason we hypothesized that a sample of
PwMS with moderate mobility impairments might bene-
fit from such intervention. Previous studies on TOCTUC (n = 12)
CI Mean (SD) Median (25th-75th Percentile) 95% CI
7 – 64.76 49.44 (20.12) 38.88 (36.11 – 72.22) 36.65 – 62.23
5 – 51.85 53.14 (19.24) 47.77 (40.00 – 72.77) 40.92 – 65.37
6 – 53.25 53.70 (16.43) 50.00 (42.77 – 65.00) 43.26 – 64.14
2 – 60.74 51.58 (18.67) 50.00 (36.25 – 68.50) 39.71 – 63.44
2 – 51.61 53.75 (18.10) 52.00 (38.50 – 70.25) 42.24 – 65.25
7 – 56.15 53.00 (22.28) 49.00 (37.00 – 71.50) 38.83 – 67.16
6 – 71.95 61.94 (18.28) 60 (47.5 – 76.67) 50.33 – 73.56
3 – 61.29 70.83 (17.08) 75 (55 – 82.5) 59.98 – 81.68
3 – 75.61 71.11 (20.34) 74.17 (55.83 – 88.33) 58.19 – 84.04
– 6.22 5.79 (0.98) 6.22 (4.77 –6.55) 5.17 – 6.42
– 6.02 6.11 (0.68) 6.11 (5.44 – 6.78) 5.68 – 6.54
– 6.13 6.01 (0.91) 6.28 (5.22 – 7) 5.51 – 6.66
le Sclerosis Impact Scale -29 (psychological and physical functions);
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stroke survivors including a wide range of exercise doses
and intensities [16]. To our knowledge (except for tread-
mill, body-weight support treadmill and robot-assisted
gait training [34]), the only attempts to apply a task-
oriented training for mobility impairments in PwMS were
done by Mark et al. [35] who proposed a Constraint-
Induced Movement Therapy (CIMT) for the lower extrem-
ities and Salbach et al. [36] who tested a community exer-
cise program for people with stroke, acquired brain injury
and MS. CIMT was administered to a small sample (n = 4)
showing positive effects on real-world lower extremity use
up to four years. Compared to our TOCT, CIMT protocol
was much more intense (3.5 h/d for 3 wk), trained 15 dif-
ferent tasks (compared to 7) and a “transfer package” to de-
liver gains into the real world was administered [35]. The
community exercise program was delivered to 2 MS sub-
jects twice/week for 12 weeks with no effects on walking
endurance [36]. Our two weeks high-intensity task oriented
circuit training was feasible and safe in a small group of
PwMS with moderate mobility impairments. We didn’t re-
port any injuries as a consequence of falls during TOCT
sessions or marked fatigability which required the interrup-
tion of the exercise; all twelve subjects concluded the 10
sessions with no drop-outs. Furthermore, looking at the
feasibility patient-reported questionnaire results, we might
conclude that this is a suitable intervention in this popula-
tion. To test TOCT effects on walking function we did
both short-distance (10MWT) than long-distance (SMWT)
walking tests in addition to a patient-reported measure of
walking ability (MSWS-12). Long-distance walking test and
patient-reported walking ability questionnaires were consid-
ered as the best measures to detect changes after rehabi-
litation in MS subjects [37]. Furthermore, long-distance
walking tests, such as SMWT better reflect walking per-
formance and functional capacity in MS population [38]. A
good predictor for independency and mobility in PwMS is
walking endurance measured by SMWT: it has been shown
that subjects have 1% increased probability of being inde-
pendent for every 1 m longer they walk during SMWT
[23]. In our sample we didn’t find significant effects on gait
speed measured with 10MWT probably because short-
distance more than long-distance walking test are due to
variability. In fact, a recent study reported a within-day vari-
ability of >20% for the 10MWT when baseline gait velocity
was <1.2 m/s [39]. Another reason would be that we didn’t
use the 25 foot walking test, which seems to be more reli-
able than 10MWT in detecting changes in PwMS [40]. Our
findings in SMWT gains were close to the minimally im-
portant change from a patient prospective stated as 22 m
[37]. In the same way MSWS-12 score improved by 11
points, showing beneficial effects on walking ability; this pa-
tient–reported outcome measure investigates limitation on
walking abilities due to MS [30] and seems to be reliable indetecting changes after rehabilitation with a minimally im-
portant change of 10.39 points [37]. Considering how
health-related quality of life is strongly reduced in PwMS
[4], we found positive effects of TOCT on both physical
and psychological functions in MSIS-29; however we have
to consider how these results are within the standard error
of the measurement which is defined as 5.3-9.5 points for
physical domain and 7.6-13 points for psychological do-
main [41,42]. Examining fatigue which is a common MS
symptom with a negative impact on mobility, activities and
quality of life, in our sample we didn’t find any detrimental
effects of the task-oriented circuit training (2h/d over 2
weeks). Accordingly with previous studies [10-12] we
highlighted a slight fatigue reduction after TOCT. Never-
theless, these preliminary results should be taken cau-
tiously, considering that this is a pilot study with the aim to
test the safety and feasibility of a task-oriented circuit train-
ing in PwMS.
In our sample we found a lower adherence to home-
exercise program (58%) compared to other studies in
MS subjects [43-45]. We can assume that giving a diary
with a home-based exercise program wasn’t sufficient to
motivate subjects to continue with task-oriented exer-
cises at home. We can also speculate that task-oriented
training is less suitable at home compared to other
intervention tested in the aforementioned studies
(mostly resistance exercises). Moreover, depression or
cognitive symptoms, that are common in MS, might
have reduced subjects’ compliance to rehabilitation, as
clearly highlighted for MS medications [46]. However,
we didn’t find any differences in walking endurance
deterioration after TOCTamong good- and poor-adherence
subgroups.
Finally, as long walking tests are more appropriate in
detecting clinically meaningful improvement after phys-
ical rehabilitation in MS population [37,38], we calcu-
lated a sample size for a future RCT study based on the
SMWT gains (51 subjects).
Limits and future directions
Our pilot study has several limitations. Firstly, our small
and heterogeneous sample didn’t allow us to draw definite
inferences from this analysis; moreover the inability to blind
subjects’ on the treatments received (TOCT or UC) might
have reduced the internal validity of the study; secondly, we
didn’t use neither a valid method to address home-exercise
adherence, nor psychiatric and neuropsychological evalu-
ation to identify possible factors related to discontinued
therapies; finally, we didn’t have real-world measures
(i.e. accelerometer or step counters) to test transfer-
ability in everyday life.
Future directions: (i) to conduct a large RCT trial to con-
firm this preliminary results with a longer follow-up; (ii) to
better explain MS mechanisms of functional recovery it
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functional near-infrared spectroscopy); (iii) to quantify the
dose of exercise delivered; (iv) to add real-world based
measures (i.e. steps counters and specific patient-reported
questionnaires); (v) to test TOCT in a wide range of mobil-
ity impairments (EDSS ≥ 6); (vi) to increase home-exercise
program adherence with different methods (i.e. customized
pamphlets, phone calls, physiotherapy visits).
Conclusions
In this pilot study, we assessed the safety, feasibility and
preliminary effects on selected variables (gait speed, gait
endurance, mobility, balance and health-related quality
of life) of a task-oriented circuit training in a sample of
multiple sclerosis subjects. Our main findings revealed
that a 2 weeks task-oriented circuit training followed by
a three months home exercise program is safe and well
tolerated in multiple sclerosis subjects with moderate
gait and mobility impairments. TOCT may allow a more
intensive (more repetitions) and specific (task oriented)
exercise in an enriched rehabilitative setting. No detri-
mental effects on subjective fatigue have been observed
in this sample or major adverse effects (i.e. fall-related
injury). Even though some positive effects on walking
ability has been underlined, this trial cannot draw defini-
tive conclusions on the effects of such intervention.
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